William Hallett

Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

Sridhar K. Rabindran, Carolyn Discafani, Edward Rosfjord et al. · Cancer Research · 2004 · 628 citations · Full text

Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity

Hwei‐Ru Tsou, Elsebe G. Overbeek-Klumpers, William Hallett et al. · Journal of Medicinal Chemistry · 2005 · 294 citations · Full text

Medicinal Chemistry, Biochemistry, Safer Cyclization Step +13

The Role of Insulin in Human Brain Glucose Metabolism

Emma Bingham, David Hopkins, Diarmuid Smith et al. · Diabetes · 2002 · 294 citations · Full text

Lactate: A Preferred Fuel for Human Brain Metabolism <i>in Vivo</i>

Diarmuid Smith, A Pernet, William Hallett et al. · Journal of Cerebral Blood Flow & Metabolism · 2003 · 275 citations · Full text

Lactate Infusion, Preferred Fuel, Brain Nutrition +20

Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)

Allan Wissner, Elsebe Overbeek, Marvin F. Reich et al. · Journal of Medicinal Chemistry · 2002 · 262 citations · Full text

Combinatorial Chemistry, Pharmaceutical Science, Bioorganic Chemistry +19